Jiangsu Hengrui Medicine
600276.SS
#494
Rank
โ‚น3.448 T
Marketcap
โ‚น540.62
Share price
-0.62%
Change (1 day)
4.22%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚น48.73 Billion

According to Jiangsu Hengrui Medicine 's latest financial reports the company's total liabilities are โ‚น48.73 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Jiangsu Hengrui Medicine - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31โ‚น47.29 B9.6%
2021-12-31โ‚น43.15 B-2.39%
2020-12-31โ‚น44.20 B65.36%
2019-12-31โ‚น26.73 B1.66%
2018-12-31โ‚น26.29 B27.83%
2017-12-31โ‚น20.57 B44.42%
2016-12-31โ‚น14.24 B21.99%
2015-12-31โ‚น11.67 B22.28%
2014-12-31โ‚น9.55 B65.75%
2013-12-31โ‚น5.76 B45.79%
2012-12-31โ‚น3.95 B6.84%
2011-12-31โ‚น3.69 B29.71%
2010-12-31โ‚น2.85 B25.74%
2009-12-31โ‚น2.26 B39.82%
2008-12-31โ‚น1.62 B-25.12%
2007-12-31โ‚น2.16 B89.85%
2006-12-31โ‚น1.14 B15.5%
2005-12-31โ‚น0.98 B-26.73%
2004-12-31โ‚น1.34 B-55.28%
2003-12-31โ‚น3.01 B31.85%
2002-12-31โ‚น2.28 B8.62%
2001-12-31โ‚น2.10 B